4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sun Pharmaceutical Industries Limited (SUNPHARMA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 47,000 employees. Its market capitalization is roughly ₹4.41 trillion. In the fiscal year ended 2026-03-31, SUNPHARMA reported ₹582.2B in revenue and ₹114.8B in net income.
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹582.2B | ₹520.4B | ₹477.6B | ₹432.8B |
| Gross Profit | ₹450.5B | ₹398.4B | ₹356.9B | ₹313.4B |
| Operating Income (EBIT) | ₹135.9B | ₹125.8B | ₹104.7B | ₹92.8B |
| Net Income | ₹114.8B | ₹109.3B | ₹95.8B | ₹84.7B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹151.8B | ₹145.6B | ₹154.7B | ₹137.9B | ₹128.2B |
| Gross Profit | ₹122.2B | ₹117.6B | ₹125.2B | ₹109.7B | ₹101.8B |
| Operating Income (EBIT) | ₹35.6B | ₹27.5B | ₹40.6B | ₹33.7B | ₹27.6B |
| Net Income | ₹28.9B | ₹27.1B | ₹33.7B | ₹22.8B | ₹21.5B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Dividends Paid | (₹39.3B) | (₹36.1B) | (₹29.0B) | (₹25.2B) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹1.09T | ₹921.0B | ₹855.0B | ₹807.4B | — |
| Total Liabilities | ₹249.1B | ₹196.1B | ₹183.7B | ₹214.3B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SUNPHARMA viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms